Eton Pharmaceuticals, Inc. - 8-K Filing

Eton Pharmaceuticals reports preliminary pilot study results for ET-700 showing improved gastrointestinal tolerability over GALZIN®.

SEC EDGAR ·

Tickers: $ETON

Read the full article at SEC EDGAR

More Regulatory news